Upifitamab (Anti-SLC34A2)

Upifitamab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize an ADC compound, Upifitamab rilsodotin, used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer. MW : 145.5 KD.
Supplier Selleck Chemicals
Product # A2351
Sku # A2351-1mg
Pricing 1mg, $470.00
Feedback